ATAI Life Sciences N.V (NASDAQ:ATAI) shares, rose in value on Tuesday, December 31, with the stock price down by -1.48% to the previous day’s close as strong demand from buyers drove the stock to $1.33.
Actively observing the price movement in the last trading, the stock closed the session at $1.35, falling within a range of $1.27 and $1.37. Referring to stock’s 52-week performance, its high was $2.85, and the low was $1.03. On the whole, ATAI has fluctuated by -25.28% over the past month.
With the market capitalization of ATAI Life Sciences N.V currently standing at about $219.87 million, investors are eagerly awaiting this quarter’s results, scheduled for in February.
Wall Street analysts also predicted that the company’s y-o-y revenues would reach 250k.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that ATAI’s technical picture suggests that short-term indicators denote the stock is a 50% Sell on average. However, medium-term indicators have put the stock in the category of Hold while long-term indicators on average have been pointing out that it is a 50% Sell.
The stock’s technical analysis shows that the price of ATAI currently trading nearly -3.20% and -3.94% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 47.16, while the 7-day volatility ratio is showing 8.26% which for the 30-day chart, stands at 8.41%. Furthermore, ATAI Life Sciences N.V (ATAI)’s beta value is 1.18, and its average true range (ATR) is 0.12.
A comparison of ATAI Life Sciences N.V (ATAI) with its peers suggests the former has fared considerably weaker in the market. ATAI showed an intraday change of -1.48% in last session, and over the past year, it shrunk by -5.67%%.
Data on historical trading for ATAI Life Sciences N.V (NASDAQ:ATAI) indicates that the trading volumes over the past 10 days have averaged 1.41 and over the past 3 months, they’ve averaged 1.41 million. According to company’s latest data on outstanding shares, there are 167.82 million shares outstanding.
Nearly 30.24% of ATAI Life Sciences N.V’s shares belong to company insiders and institutional investors own 7.14% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 10.61 million shares as on 2024-12-13, resulting in a short ratio of 5.49. According to the data, the short interest in ATAI Life Sciences N.V (ATAI) stood at 828.00 of shares outstanding as of 2024-12-13; the number of short shares registered in 2024-11-15 reached 9.87 million. The stock has fallen by -5.67% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the ATAI stock heading into the next quarter.
